“gary-glick” Archives

Entry Author Date Location
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator 12/02/19 Boston
New Faces, Big Impact: Meet the Finalists For Xconomy’s Newcomer Award 08/07/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
The Revolution in Inflammation Drug Development 05/15/18 Boston
Last Chance to Save on Boston’s Life Science Disruptors 09/20/17 Boston
IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout 08/03/17 Boston
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout 06/11/15 Detroit Ann Arbor
Lycera Enters Into Second Collaboration Deal with Merck 02/12/13 Detroit Ann Arbor
Who Needs a CEO? Lycera Strikes Deal with Pharma Giant Merck 03/03/11 Detroit Ann Arbor
Lycera Plows Ahead With Drugs To Treat Autoimmune Disorders 02/24/11 Detroit Ann Arbor
Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence 09/17/10 Detroit Ann Arbor
Rising from the Ashes of Pfizer: The Michigan Contract Research Organization Cluster 07/01/10 Detroit Ann Arbor
It Seems Everybody Has Advice For Michigan; What Do You Think? 05/06/10 Detroit Ann Arbor
Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs 04/28/10 Detroit Ann Arbor
Four Key Ingredients Needed to Spark Innovation in Michigan 04/26/10 Detroit Ann Arbor
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Page 1 of 1